DENVER, Dec. 16, 2010 (GLOBE NEWSWIRE) — MusclePharm(R) Corporation (OTCBB:MSLP – News), one of the fastest growing nutritional supplement companies in the United States, announced that the Company will be a title sponsor at tonight's WEC 53 Event in Arizona where the MusclePharm logo will be featured in two places on the mat.
MusclePharm is one of five WEC title sponsors including, Bud Light, Harley Davidson, Pepsi and TapouT. The fight, with a regular viewing audience of more than one million people, will be televised live on Versus Network at 9 p.m. Eastern Time. MusclePharm will also run two 30-second in venue commercials.
"The fight will serve as another incredible showcase for the MusclePharm brand," commented Cory Gregory, MusclePharm's President. "MusclePharm is extremely pleased to have the opportunity to work with the WEC and their athletes who garner such strong interest and viewership."
Tonight the WEC Organization will stage its last card with Champion Benson Henderson taking on Anthony Pettis for the chance to fight the winner of the Frankie Edgar/Gray Maynard fight early in 2011.
Headquartered in Denver, Colorado, MusclePharm is a rapidly expanding healthy life-style company that develops and manufactures a full line of NSF and scientifically approved, nutritional supplements that are 100% free of any banned substances. Based on years of research, MusclePharm products are created through an advanced six-stage research protocol involving the expertise of top nutritional scientists and field tested by more than 100 elite professional athletes from various sports including the NFL, MMA, and MLB. The Company's propriety and award winning products address all categories of an active lifestyle including muscle building, weight loss, and maintaining general fitness through a daily nutritional supplement regimen. MusclePharm is sold in over 120 countries and available in over 5,000 U.S. retail outlets that include GNC, and Vitamin Shoppe, as well as over 100 online stores, including bodybuilding.com, Amazon and Vitacost.com. For more information, please visit www.musclepharm.com.
MusclePharm Corporation believes the information set forth in this Press Release may include "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. Certain factors that could cause results to differ materially from those projected in the forward-looking statements are set forth in "Risk Factors" in Item 2.02 of the Company's Form 8-K dated February 18, 2010, which has been filed with the Securities and Exchange Commission.